Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06705790

Exploring the Benefits of Pelvic Floor Muscle Training on Bladder, Bowel, and Sexual Function in People With Spinal Cord Injury

The goal of this trial is to learn about the feasibility and benefits of delivering a pelvic floor muscle training program to people with motor-incomplete spinal cord injury. The main questions it aims to answer are:

1. To evaluate the feasibility of delivering a pelvic floor muscle training program to people with spinal cord injury. The investigators will examine recruitment rate, compliance and adherence to the intervention and other study protocols, adverse events, and participant perspectives of the study protocols. 2. To explore the potential effectiveness of pelvic floor muscle training on pelvic floor, bladder, bowel, and sexual function.

Participants will be asked to complete a pelvic floor muscle training program for 3 months. At the beginning, middle, and end of the program, researchers will conduct a series of tests to determine the feasibility and potential effectiveness of this program.

Recruiting

Interested in participating?

Request Info

Key information

Age range

19 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Blusson Spinal Cord Centre

Vancouver, British Columbia, V5Z1M9, Canada

Location status: Recruiting

Location contact

Alison Williams

CONTACT

[email protected]

604-675-8815

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Are at least 19 years of age.
  • Have a non-progressive, motor-incomplete spinal cord injury that is at or above the T12 neurological level at least 12 months ago.
  • Have symptoms of bladder, bowel, and/or sexual dysfunction that are caused by your spinal cord injury.
  • Have stable management of spinal cord related secondary health concerns (e.g., spasticity, neuropathic pain).
  • Are able to speak and understand English.

Exclusion criteria

  • Are currently pregnant, have been pregnant within the past 6 months, or are planning to become pregnant in the next 6 months.
  • Have had urogenital surgery within the past 12 months.
  • Have received Botox bladder injections within the past 4 weeks, or anticipate receiving an injection in the next 6 months.
  • Have presence of severe medical issue that in the investigator's judgement would adversely affect the participant's participation in the study. Examples include, but are not limited to pressure sores, cardiovascular disease, and unmanaged diabetes.
  • Have any permanent metal fixtures in their head (excluding dental fillings), or pacemakers, stimulators, or implanted medication pumps.
  • Have a history of seizures, are taking medications that lower the seizure threshold, or experience recurring headaches.
  • Have a condition for which exercise is contraindicated.

Treatment and study plan

Pelvic floor muscle training

Behavioral

Pelvic floor muscle training 5x/week for 12-weeks

Primary outcomes

  1. Feasibility - Recruitment Rate

    Time frame: Through study completion, up to 12 weeks

    Recruitment rate will be evaluated by number of participants approached, screened for eligibility, as well as reasons for exclusions.

  2. Feasibility - Compliance

    Time frame: Through study completion, up to 12 weeks

    Compliance will be tracked by the adherence of participants to the prescribed exercise program, with reasons for missed sessions or drop-outs noted.

  3. Feasibility - Adverse Events

    Time frame: Through study completion, up to 12 weeks

    Any adverse events to study protocols will be recorded.

  4. Feasibility - Acceptability

    Time frame: Through study completion, up to 12 weeks

    The acceptability of the intervention will be evaluated using a 7-point Likert scale to rate participants' enjoyment of the exercise program and whether they felt the program was beneficial for improving their bladder, bowel, and/or sexual function.

Secondary outcomes

  1. Incontinence Quality of Life Questionnaire (I-QoL)

    Time frame: From enrollment to within 2 weeks of completing the study intervention

    Participants will be asked to respond to 22 questions about how urinary incontinence impacts their quality of life using a 5-point scale with values ranging from 1 (extremely) to 5 (not at all). The questionnaire probes three subdomains of how incontinence may affect quality of life: avoidance and limiting behavior, psychosocial impact, and social embarrassment.

  2. Neurogenic Bladder Symptoms Score (NBSS)

    Time frame: From enrollment to within 2 weeks of completing the study intervention

    Participants will be asked to respond to 24 questions regarding the severity of their bladder symptoms secondary to neurological injury. Questions cover three subdomains: incontinence, storage and voiding, and consequences.

  3. 3-Day Bladder Diary

    Time frame: From enrollment to within 2 weeks of completing the study intervention

    Participants will be asked to record information regarding their fluid intake (i.e., time, volume, and type) and voids (i.e., time, volume, leaks, and pad change) for three days. The investigators will use the combined information on intake and voids to make a clinical summary of the participants urinary function.

  4. Timed Bowel Movement

    Time frame: From enrollment to within 2 weeks of completing the study intervention

    Participants will be asked to how long their bowel movements take, and what (if any) aids they used to complete the bowel movement (e.g. suppository, laxatives, digital stimulation/evacuation, etc).

  5. Neurogenic Bowel Dysfunction Score (NBDS)

    Time frame: From enrollment to within 2 weeks of completing the study intervention

    Participants will be asked to complete the NBDS which asks 11 questions to clinically assess the severity of their bowel dysfunction symptoms. Results of this questionnaire provide a score from 0 to 47, where a higher score represents more severe bowel symptoms.

  6. International Index of Erectile Function (IIEF) Questionnaire (Males only)

    Time frame: From enrollment to within 2 weeks of completing the study intervention

    Male participants will be asked to complete the IIEF questionnaire which askes 15 questions to clinically assess sexual health in 5 domains: erectile function (possible score of 0-30), orgasmic function (possible score of 0-10), sexual desire (possible score of 0-10), intercourse satisfaction (possible score of 0-15), overall satisfaction (possible score of 0-10). In all domains, a higher score represents more severe sexual dysfunction.

  7. Female Sexual Function Index (FSFI) Questionnaire (Females Only)

    Time frame: From enrollment to within 2 weeks of completing the study intervention

    Female participants will be asked to complete the FSFI questionnaire which askes 19 questions to clinically assess sexual health in 6 domains: desire (possible score of 1.2-6), arousal (possible score of 0-6), lubrication (possible score of 0-6), orgasm (possible score of 0-6), satisfaction (possible score of 0.8-6), and pain (possible score of 0-6). In all domains, a higher score represents a less sexual dysfunction.

  8. Sexual Quality of Life Questionnaire - Male/Female

    Time frame: From enrollment to within 2 weeks of completing the study intervention

    Male and female participants will both be asked to complete their sex-specific version of this questionnaire. This questionnaire asks respondents to rate 11 statements (male, possible score of 11-66) or 18 statements (female, possible score of 18-108) according to how much they agree or disagree with it. For both the male and female version of the questionnaire, a higher score represents better sexual quality of life.

  9. Pelvic Floor Electromyography

    Time frame: From enrollment to within 2 weeks of completing the study intervention

    PFM function (i.e., endurance and motor control) will be assessed using surface electromyography (EMG). Disposable surface electrodes will be placed perianally to record from the pelvic floor muscles, and other electrodes will be placed over the relevant muscles in the trunk and legs. Participants will be asked to attempt various contractions of their pelvic floor muscles including a maximal, isolated pelvic floor contraction; a sustained pelvic floor contraction to assess endurance; and a rapid contract-relaxation task to assess motor control.

  10. Effectiveness of Cueing

    Time frame: From enrollment to within 2 weeks of completing the study intervention

    Researchers will ask participants about their perceived effectiveness of verbal instructions and feedback strategies used in the pelvic floor muscle training sessions for facilitating voluntary activation of the pelvic floor.

  11. Transcranial Magnetic Stimulation (TMS) Assessment

    Time frame: From enrollment to within 2 weeks of completing the study intervention

    The investigators will assess the connection of the neural pathways between the brain and pelvic floor using transcranial magnetic stimulation (TMS). TMS will be delivered over the primary motor cortex in the brain, and motor evoked potentials (MEPs) will be recorded using surface electromyography from the pelvic floor. Participants will be instruction to maintain a sub-maximal contraction of the pelvic floor during the experiment, while TMS pulses are delivered at a variety of intensities.

  12. Pudendal Somatosensory Evoked Potential (SEP) Assessment

    Time frame: From enrollment to within 2 weeks of completing the study intervention

    Pudendal nerve function will be assessed through an somatosensory evoked potential (SEP) assessment. Non-painful electrical stimulations of up to 1ms in duration will be delivered to the pudendal nerve via the electrodes placed over the genitals while the investigators simultaneously use an electroencephalography (EEG) cap to record from the somatosensory cortex.

  13. Transperineal Ultrasound

    Time frame: From enrollment to within 2 weeks of completing the study intervention

    Pelvic floor muscle function will be assessed through transperineal ultrasound. An ultrasound probe will be placed on the perineum to visualize the pelvic floor and other relevant pelvic structures (e.g. bladder, urethra, vaginal canal, sphincters, pelvic bones). Ultrasound images and recordings will be taken while the participant is at rest and as they attempt PFM contractions.

Study contacts

Contact information is provided by the study sponsor or research team.

Alison Williams

CONTACT

[email protected]

604-675-8815

Sponsors and collaborators

Lead sponsor

University of British Columbia

Other

Registry information

Official study title

Exploring the Feasibility and Urogenital Benefits of Pelvic Floor Muscle Training in Individuals With Motor-incomplete Spinal Cord Injury

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Nov 26, 2024
Registry last updated
May 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.